Thomas Isiah III 4
4 · One World Pharma, Inc. · Filed Apr 6, 2021
Insider Transaction Report
Form 4
Thomas Isiah III
DirectorCEO and Chairman
Transactions
- Award
Series B Preferred Stock
2021-04-05$15.00/sh+16,666$249,990→ 83,333 total(indirect: See FootNote)Exercise: $0.15From: 2021-04-05→ Common Stock (1,666,600 underlying)
Footnotes (2)
- [F1]The Series B Preferred Stock does not have an expiration date.
- [F2]The securities were purchased by ISIAH International LLC. The reporting person owns all of the membership interests in ISIAH International LLC and is its Chairman and Chief Executive Officer.